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A key function of activated macrophages is to se-
crete proinflammatory cytokines such as TNF; how-
ever, the intracellular pathway and machinery respon-
sible for cytokine trafficking and secretion is largely
undefined. Here we show that individual SNARE
proteins involved in vesicle docking and fusion are
regulated at both gene and protein expression upon
stimulation with the bacterial cell wall component
lipopolysaccharide. Focusing on two intracellular
SNARE proteins, Vti1b and syntaxin 6 (Stx6), we show
that they are up-regulated in conjunction with in-
creasing cytokine secretion in activated macrophages
and that their levels are selectively titrated to accom-
modate the volume and timing of post-Golgi cytokine
trafficking. In macrophages, Vti1b and syntaxin 6 are
localized on intracellular membranes and are present
on isolated Golgi membranes and on Golgi-derived
TNF vesicles budded in vitro. By immunoprecipita-
tion, we find that Vti1b and syntaxin 6 interact to form
a novel intracellular Q-SNARE complex. Functional
studies using overexpression of full-length and trun-
cated proteins show that both Vti1b and syntaxin 6
function and have rate-limiting roles in TNF traffick-
ing and secretion. This study shows how macrophages
have uniquely adapted a novel Golgi-associated
SNARE complex to accommodate their requirement
for increased cytokine secretion.
A primary function of activated macrophages is the rapid
and abundant secretion of proinflammatory cytokines such as
TNF.1 This secretion is essential to mount a successful in-
flammatory response but is equally the cause of severe clinical
problems in acute and chronic inflammatory disease (1). The
bacterial cell wall component LPS activates macrophages, elic-
iting the rapid synthesis of TNF as a type II membrane
precursor and subsequent proteolytic cleavage for secretion of
the active cytokine (2–4). Newly synthesized TNF precursors
accumulate in the Golgi complex (5, 6); thereafter, little is
known about the secretory pathway, the specific trafficking
machinery or mechanisms that ensure the rapid delivery of
cytokine to the cell surface for release.
SNAREs are key regulators in all fusion events occurring in
the secretory pathway (7). Vesicle docking and fusion requires
a specific R-SNARE on the vesicle to bind to two or three
unique receptor target molecules, the Q-SNAREs, on the target
membrane to form a trans-complex, thus pulling the mem-
branes in close proximity and overcoming the energy barrier for
fusion (8, 9). Four different conserved SNARE motifs (Qa, Qb,
Qc and R) form an extended four-helix bundle and are suffi-
cient for complex formation. Distinct complexes of SNARE fam-
ily proteins are required to mediate vesicle docking and fusion
on different membranes and at different vesicle trafficking
steps (7, 10). The best characterized of the SNARE complexes
functions in the fusion of synaptic vesicles at the plasma mem-
brane. Intracellular SNARE complexes tend to be less well
defined for a number of reasons; SNARES can participate in
multiple fusion steps throughout the cell and as such can
interact with different sets of SNARE partners. Additionally,
differences in SNARE complexes and localization can exist
between cell types.
Syntaxin 6 is a promiscuous SNARE partner, implicated in
multiple complexes and associated with functions in both exo-
cytic and endocytic pathways (11). It typically resides on
membranes and vesicles in and around the trans-Golgi net-
work (TGN). Vti1b is known in a much more restricted con-
text, that of a single SNARE complex on late endosomes,
where it has been implicated in late endosome homotypic
fusion and in late endosome-lysosome fusion (12, 13). There
is also evidence that it interacts with EpsinR, a protein
involved in exocytic trafficking (14, 15).
A number of SNARE proteins have been identified in macro-
phages (16–18). VAMP3 has been shown to function in the
formation of phagosomes (19), and we have shown that the
Q-SNARE complex of syntaxin 4 and SNAP23, along with
the sec1/Munc18 family (SM) protein Munc18c, functions at the
plasma membrane and is required for TNF secretion in
macrophages (20). The majority of the molecules involved in
regulating vesicle budding from the Golgi and the transport to
and fusion with the target membrane remain to be identified in
macrophages. Here we show that a novel Q-SNARE complex,
located on similar Golgi-derived vesicles as TNF, is up-regu-
lated at a rate-limiting step in the secretion of TNF to maxi-
mize cytokine secretion during inflammation.
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MATERIALS AND METHODS
Antibodies and Reagents—Anti-mouse TNF antibodies were pur-
chased from Genzyme, anti-syntaxin 3 antibodies were purchased from
Sapphire Biosciences, and anti--tubulin antibodies were purchased
from Molecular Probes. Antibodies specific for VAMP2, VAMP8, Stx7,
Stx8, and SNAP-23 were purchased from Synaptic Systems, whereas
antibodies to Vti1A, Vti1B, Stx6, GS28, -adaptin, and GM130 were
purchased from BD Biosciences. Antibodies to Munc-18c were a kind
gift from David James (Garvan Institute of Medical Research, Sydney,
Australia). Antibodies to -COP were a kind gift from Rohan Teasdale
(Institute for Molecular Bioscience, Brisbane, Australia).
Cell Culture, Molecular Cloning, and Electroporation—RAW264.7
murine macrophages were cultured and activated with LPS as de-
scribed previously (20). In some experiments, macrophages were incu-
bated for 18 h in the presence of 500 pg/ml interferon- (IFN-) prior to
treatment with LPS. SNARES (both full-length and truncated) were
cloned into the pEGFP-C2 vector (Clontech, BD Biosciences) to produce
an N-terminal GFP-tagged protein. Syntaxin 2 was subcloned from a
National Institute of Aging clone (parent clone ID J0828A07). For
syntaxin 2 (amino acids 4–265) PCR amplification, the following oligo-
nucleotides were used: 5-tatgaattcatgcgggaccggctgcccga-3 and 5-gaat-
tacccgggtcatttgccaaccgacaagc-3. Stx6 was subcloned from a Riken Fan-
tom clone (accession number AK019106) using the following
oligonucleotides: 5-actgaattcatgtccatggaggacccctt-3 and 5-gcggatccct-
cacagcactaggaagagga-3 or 5-gtggatccctcactggcgccgatcactggtca-3. Vti1B
was subcloned from a NIA clone (parent clone ID L0280F09) using the
following oligonucleotides: 5-aatgaattcatggccgcctccgccgcctc-3 and 5-
accgttcccgggtcaatggtgtcgaaagaatt-3 or 5-gcggatccctcacagcaacttgttggt-
tatca-3. Macrophages were electroporated, using Gene Pulser II (Bio-
Rad), for transient expression of cDNAs using 2.5 107 cells with 10 g
DNA, with a high capacitance setting (280 mV and 950 microfarads).
Cells were washed and typically cultured for 24 h.
Microarray Analysis—RAW 264.7 macrophages, cultured in the pres-
ence of LPS (100 ng/ml) for varying times were extracted for mRNA,
and microarray analysis was performed according to the protocol of
Ref. 21.
Immunoblotting, Immunoprecipitation, and Immunofluorescence
Staining—Cells were washed three times with Buffer A (10 mM Tris,
pH 7.4, containing 1 mM EDTA, 0.5% Triton X-100, and CompleteTM
protease inhibitors (Roche Applied Science)) and lysed in Buffer A by
passage through a series of successively smaller needles. The lysate was
centrifuged at 17,000  g for 10 min at 4 °C, and the supernatant was
assayed for protein content (Bio-Rad protein assay), subjected to SDS-
PAGE separation, and analyzed by immunoblotting (20). For immuno-
precipitation, the cell lysate was incubated with 5 g of antibody bound
to protein A-Trisacryl beads (Pierce) for 2 h at 4 °C with constant
mixing. The beads were then washed five times in excess Buffer A
containing 150 mM NaCl, and the bound proteins were solubilized in
SDS-PAGE sample buffer. Immunofluorescent staining was performed
as previously published (20).
Golgi Membrane Isolation and in Vitro Vesicle Budding—A stacked
Golgi membrane fraction and subsequent budded vesicles were pre-
pared from RAW264.7 cells stimulated with LPS (100 ng/ml) for 2 h by
density gradient centrifugation based on previously published methods
(22, 23). The resulting fractions were analyzed by SDS-PAGE and
immunoblotting.
Assays for TNF Trafficking and Secretion—The trafficking of TNF
from the Golgi complex to the cell surface was measured using an
immunofluorescence-based assay described previously (20). A commer-
cial enzyme-linked immunoabsorbent assay kit (BD OptEIA, BD Bio-
sciences) was used according to the manufacturer’s instructions to
determine levels of secreted TNF.
RESULTS
SNARE Expression Is Quantitatively Linked to Exocytic
Trafficking Requirements in Activated Macrophages—In acti-
vated macrophages, TNF secretion is temporal in nature;
the pulse of TNF protein synthesis peaks at 2 h and ceases
by 12 (Fig. 1) (5). Identifying components of the trafficking
machinery of the cell that are similarly regulated by LPS
during this period provides a strategy for identifying proteins
involved in the secretory process (20). We have previously
shown that a plasma membrane Q-SNARE complex of syn-
taxin 4 and SNAP23, along with Munc18c, is up-regulated by
LPS and that it functions in TNF delivery to the cell surface
(20). Microarrays were now used in a wider screen to search
FIG. 1. SNARE expression is quantitatively linked to exocytic traffic.A, RAW264.7 cells were stimulated with LPS (100 ng/ml) over a time course
and extracted for either protein or RNA. Changes at the gene level were analyzed by microarray analysis (Affymetrix Moe430A chip), whereas changes at
the protein level were analyzed by immunoblotting on gel lanes with matched protein loading, using antibodies to TNF and to the SNARE proteins Stx6
and Vti1b.B, macrophages were activated with LPS (100 ng/ml) for 2 h with or without prior priming with IFN- (500 pg/ml) for 18 h, fixed, permeabilized,
and immunostained for TNF. In unprimed cells, TNF is at the Golgi complex and on the cell surface. Priming increases the intensity of staining at the
Golgi and on the cell surface, and TNF is now also seen in endosomes after internalization of uncleaved surface TNF (6). C, macrophages were activated
with LPS for the times indicated with or without prior priming with IFN- for 18 h. Cell extracts were analyzed by immunoblotting using antibodies to Stx6
or Vti1b. D, bar chart, with S.E., shows that the up-regulation of Stx6 and Vti1b is shifting to the left and occurs more rapidly in IFN--primed activated
cells as compared with unprimed activated cells.
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for other LPS-restricted SNARE proteins in activated macro-
phages (Affymetrix, 430A mouse gene chip; results published
at Gene Expression Omnibus (GEO), accession number
GSE1459, www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc
GSE1459). A characteristic response to LPS by these macro-
phages was signified by the dramatic induction of inflamma-
tory cytokine genes, including up-regulation of TNF itself
(Fig. 1A). Two SNARE genes of interest were selected from
this screen as potential regulators of TNF trafficking, Stx6
and Vti1b, which showed significant increases in expression
at both mRNA and protein levels in response to LPS
(Fig. 1A), coinciding with the onset of TNF synthesis. The
data show that Stx6 is regulated at the gene level, whereas
the early (2 h) rise in Vti1b protein precedes up-regulation at
the gene level, suggesting some additional degree of post-
translational regulation.
Murine macrophages primed with IFN- followed by activa-
tion with LPS make 5-fold more TNF and secrete 2-fold
more TNF than cells activated with LPS alone (5) (Fig. 1B).
Thus, in IFN--primed cells, there is more TNF synthesized,
and it is trafficked to the cell surface faster than in unprimed
cells. IFN--primed LPS-activated macrophages were found to
produce an increase in Stx6 and Vti1b protein levels (Fig. 1, C
and D). Thus, in macrophages, Stx6 and Vti1b are regulated by
the same signaling pathways as TNF, and they are both
up-regulated to match the need for TNF trafficking.
Stx6 and Vti1B Partially Colocalize at the Golgi and Are Part
of the Same SNARE Complex—Antibodies to Stx6 and Vti1b
were used to localize the endogenous proteins in macrophages.
Stx6 staining was found on the perinuclear Golgi complex,
where it colocalized with newly synthesized TNF and in scat-
tered vesicles (Fig. 2A). Some staining of Vti1b was associated
with the Golgi complex, also overlapping with TNF, whereas
additional Vti1b was on endosome-like structures (Fig. 2B).
The finding that both Stx6 and Vti1b are associated with the
Golgi complex suggests that both may have a possible role in
the secretory pathway. We next investigated the biochemical
nature of SNARE complexes in activated macrophages involv-
ing these two proteins. Typically, a complete trans-SNARE
complex consists of three Q-SNARE chains (Qa,b, and c) and
one R-SNARE polypeptide chain (24). Immunoprecipitation
from activated macrophage extracts shows that in these cells,
Vti1b is part of at least two distinct SNARE complexes (Fig.
2C). In the first, Vti1b (Qb) is able to complex with its known
endosomal SNARE partner proteins Stx7 (Qa), Stx8 (Qc), and
VAMP8 (R) (Fig. 2C). In the second, a novel complex, Vti1b,
coimmunoprecipitates with Stx6 (Qc) and Stx7 (Qa) (Fig. 2C). A
cognate R-SNARE for the Vti1b/Stx6 complex at this stage is
unknown. Stx8 and VAMP8 (R) are not involved in this novel
complex in macrophages (Fig. 2C). Another SNARE Vti1A (Qb)
was also found to be expressed in macrophages, and it com-
plexes with Stx6 (Qc) but not with Vti1b (Qb) as dictated by the
stoichiometery of the Qa,b, and c SNARE complex. Similar
complexes were also immunoprecipitated from unactivated
macrophages (data not shown). Thus, Vti1b and Stx6 are com-
ponents of a novel SNARE complex. Since immunostaining
showed that Vti1b and Stx6 were both present in the Golgi
region, this is a possible site for their interaction and function.
Stx6 and Vti1B Are Found on Similar Golgi-derived Carriers
to TNF—to test the association of Vti1B and Stx6 with the
Golgi complex and secretory pathway in these cells, a biochem-
ical approach was used. We isolated a stacked Golgi fraction
from extracts of LPS-treated macrophages. Both Vti1B and
Stx6 recovered in Golgi fractions (Fig. 3A). Next, Golgi mem-
branes were incubated in vitro in the presence of cytosol and
GTPs to initiate the budding of membrane carriers. As we
have previously shown, this leads to the generation of a variety
of Golgi-derived vesicles that can be segregated by sucrose
gradient analysis (22, 23). Vti1B and Stx6 were recovered on
remnant Golgi membranes and in the fraction containing total
budded vesicles. These vesicles or carrier membranes were
further separated on a sucrose gradient. Effective vesicle bud-
ding was demonstrated by the de novo membrane binding of
the cytosolic coatomer protein -COP and the presence of
-adaptin in slightly different fractions (Fig. 3B). Both Vti1B
and Stx6 were detected on a subset of membrane carriers
budding off the Golgi, both comigrating in the same fractions as
TNF (Fig. 3B). These results show that Vti1B and Stx6 are
both associated with carriers containing TNF that bud from
the Golgi complex. Thus, both SNARE proteins are in a position
to influence exocytosis.
Vti1B and Stx6 Function in the Exocytic Pathway—Since
Vti1B and Stx6 are up-regulated in activated macrophages,
form a SNARE complex, and are found in similar Golgi-derived
FIG. 2. Stx6 and Vti1b localize to the perinuclear Golgi com-
plex and are part of the same Q-SNARE complex. A, unstimulated
cells were fixed, permeabilized, and immunostained for Stx6 in conjunc-
tion with TNF or -COP. Stx6 colocalizes with each protein in the
Golgi region and gives additional vesicular staining. B, cells immuno-
stained for Vti1b along with TNF or -COP also show colocalization at
the Golgi complex and additional Vti1b on vesicular or endosome-like
structures. C, RAW264.7 cells were stimulated with LPS for 2 h and
lysed, and extracts were incubated with antibodies to Vti1a, Vti1b,
Stx7, Stx8, or Vamp8 bound to protein A-Trisacryl beads. Precipitates
were analyzed by SDS-PAGE and immunoblotting. Vti1b coimmuno-
precipitates include Stx6 and Stx7 or Stx7 and Stx8. As a control we
show that Vti1A is not part of a complex with Vti1b and that Stx6 is not
part of a complex with Stx8 as dictated by SNARE stoichiometery. IP,
immunoprecipitation; WB, Western blot.
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carriers to the cargo TNF, functional studies were performed
to test whether Vti1B and Stx6 operate in the exocytic pathway
in macrophages. Overexpression of full-length SNARE proteins
is known to enhance their function (20, 25), whereas overex-
pression of the cytoplasmic portions of these proteins is known
to act as competitive inhibitors, blocking trans-SNARE com-
plex formation and thereby inhibiting vesicle docking and fu-
sion. The staining patterns of GFP-tagged full-length Stx6 and
Vti1b resembled the endogenous proteins (Figs. 4 and 5).
Transfected, LPS-activated cells were assayed by enzyme-
linked immunosorbent assay to measure TNF secretion into
the medium (5) and by immunofluorescence to measure the
effect on transport of TNF from the Golgi complex to the cell
surface (20). A 1.8-fold increase in TNF secreted into the
medium was recorded from GFP-Vti1b transfected cells (Fig.
4A). This coincided with an increase in TNF trafficking to the
cell surface, measured as increased cell surface staining of
TNF, in cells overexpressing full-length GFP-tagged Vti1b, as
compared with surrounding untransfected cells (Fig. 4A). No
effect on surface delivery was seen in cells overexpressing GFP
alone (data not shown). Conversely, expressing the inhibitory
cytoplasmic domain of Vti1b (GFP-Vti1b amino acids 1–234)
greatly reduced cell surface delivery of TNF in the majority of
cells (Fig. 4C). Subsequent immunostaining of permeabilized,
transfected macrophages revealed that TNF was still evident
at the level of the Golgi complex, indicating that its post-Golgi
FIG. 3. Stx6 and Vti1b are found on similar Golgi-derived vesicles carrying TNF. A, macrophages activated with LPS for 2 h were
fractionated into a stacked Golgi fraction (Golgi stacks) and cytosol. Golgi stacks were incubated with cytosol in an in vitro budding reaction, which
resulted in the following fractions: remnant Golgi, cytosol and vesicles, remnant cytosol, and budded vesicles. Samples of these fractions were
analyzed by immunoblotting. Golgi stacks are denoted by the presence of the marker GM130. Budded vesicles are enriched in the coatomer protein
-COP as compared with the original Golgi stacks and have -adaptin as a coated vesicle marker. Vti1b and Stx6 fractionate with isolated Golgi
stacks collected during the fractionation procedure. After budding, they are both on remnant Golgi and in the budded vesicle fraction. B,
Golgi-derived vesicles from the in vitro budding reaction were separated on a sucrose gradient. TNF, Vti1b, and Stx6 separate into Golgi-derived
carriers in the same subsets of fractions (F2–F5).
FIG. 4. Vti1b functions in TNF
secretion. A, RAW264.7 macrophages
transiently expressing either GFP-Vti1b
or GFP alone were treated with LPS for
2 h, and TNF in the medium was quan-
tified using an enzyme-linked immu-
nosorbent assay. The results of three ex-
periments are shown in the graph along
with S.E. The level of TNF secreted is
increased from cells overexpressing Vti1b
as compared with those expressing GFP
alone. B, cells expressing GFP-Vti1b were
treated with LPS for 2 h in the presence of
TACE inhibitor and immunostained for
surface TNF. At least 50 transfected
cells were analyzed in triplicate. GFP-
Vti1b-expressing cells consistently
showed increased surface TNF. C, cells
expressing the cytoplasmic domains of
Stx2 and Vti1b fused to GFP were treated
with LPS in the presence of TACE inhib-
itor and stained for surface TNF. More
than 50 transfected cells were measured
in each of three experiments, and the re-
sults are shown in the graph along with
S.E. Both GFP alone and the cytoplasmic
domain of Stx2 had no effect on surface
TNF staining, whereas Vti1b cytoplas-
mic domain significantly reduced this
staining. Cells expressing the cytoplasmic
domain of Vti1b were immunostained af-
ter permeabilization (Perm, lower panel)
to show that TNF is still being synthe-
sized and is present in the Golgi complex.
Unperm, unpermeabilized; aa, amino
acids.
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trafficking, but not its synthesis, had been affected (Fig. 4C).
Syntaxin 2 does not play a role in TNF secretion (20), and
overexpression of its cytoplasmic domain had no discernable
effect on TNF surface delivery (Fig. 4C) as a negative control.
Thus, by several analyses, we demonstrated for the first time a
functional role for Vti1b in the exocytic trafficking pathway.
Moreover its expression is rate-limiting since increasing the
levels of Vti1b enhanced the exocytosis of TNF. The expres-
sion and function of Stx6 was similarly tested. A 1.3-fold in-
crease in TNF secreted into the medium was recorded in
cultures overexpressing GFP-tagged Stx6 as compared with
those expressing GFP-alone (Fig. 5A). Overexpression of full-
length GFP-Stx6 revealed an increase in TNF surface stain-
ing in transfected cells as compared with surrounding untrans-
fected cells (Fig. 5B). In contrast, when the inhibitory
cytoplasmic domain of Stx6 (GFP-Stx6 amino acids 1–208) was
expressed in activated macrophages, cell surface TNF was
dramatically reduced in the majority of cells as compared with
surrounding untransfected cells (Fig. 5C). Thus, by several
analyses, we demonstrated that Vti1B and Stx6 function in the
post-Golgi secretory trafficking of TNF to the cell surface in
activated macrophages. Moreover its expression is also rate-
limiting since increasing the levels of Stx6 at the level of the
Golgi enhanced the exocytosis of TNF.
DISCUSSION
We show here a new site and a novel SNARE complex in-
volved in the quantitative regulation of the secretory pathway
in activated macrophages, providing these cells with increased
capacity to generate vesicle carriers at the level of the TGN for
post-Golgi transport of cytokine. In other hematopoietic cells,
SNARE complexes on secretory granules mediate regulated
secretion, for instance, the Stx2-SNAP-23 complex on platelet
granules (26) and the Stx4-SNAP-23 complex on eosinophilic
granules (27). In macrophages, cytokines are not stored for
release in granules but must be newly made upon cell activa-
tion and released in a battery of small vesicular carriers leav-
ing the TGN. Our current data show that key SNAREs at the
level of the TGN together with the cell surface SNARE complex
(20) are rate-limiting for cytokine secretion. Up-regulating
SNAREs at both ends of the secretory pathway is thus a coor-
dinated and essential process to increase vesicular traffic.
We have shown that the intracellular Q-SNAREs Stx6 and
Vti1b are regulated by the same signaling pathways as TNF
and that they are both up-regulated to match the need for
TNF trafficking. The rapid increase in protein levels implies
that these SNAREs may be regulated by posttranslational
mechanisms as well as at a transcriptional level, as indeed is
TNF itself (6, 28). Together with our previous findings (20), it
now appears that multiple SNARE proteins are subject to
regulated expression during macrophage activation. Little is
known about the regulation of SNARE expression in differen-
tiated cells; one other study in melanocytes suggests that the
expression of several SNARE proteins increases during cell
differentiation, concomitant with melanosome formation and
trafficking (29).
Experimental overexpression of each protein increases
TNF surface delivery and secretion, and the timing of expres-
sion of the endogenous proteins in IFN--primed macrophages
appears to be tightly linked to the timing and amount of TNF
trafficking in activated macrophages. Blocking Vti1b and Stx6
function trapped TNF in the Golgi complex, suggesting that
both are required for a step in post-Golgi exocytosis. This is the
first described role for Vti1b in an exocytic pathway. The sim-
ilar effects obtained by manipulating either Stx6 or Vti1b are
consistent with the two proteins functioning as part of the same
complex in the secretory pathway. By immunoprecipitation,
FIG. 5. Stx6 functions in TNF secretion. A, macrophages expressing either GFP-Stx6 or GFP alone were treated with LPS for 2 h; TNF
in the medium was quantified using an enzyme-linked immunosorbent assay. The results of three experiments are shown in the graph along with
S.E. TNF secretion is increased in cells overexpressing GFP-Stx6 as compared with those expressing GFP alone. B, cells transiently expressing
GFP-Stx6 were treated with LPS for 2 h in the presence of TACE inhibitor and immunostained to detect surface TNF, which was then assessed
on GFP-labeled cells as compared with surrounding cells. At least 50 transfected cells were analyzed in each of three different experiments.
Staining consistently showed increased surface TNF on GFP-Stx6-expressing cells. C, cells expressing the cytoplasmic domains of Stx2 and Stx6
fused to GFP were treated with LPS in the presence of TACE inhibitor for 2 h and stained for surface TNF. More than 50 transfected cells were
measured in each of three experiments, and the results are shown in the graph along with S.E. Both GFP alone and the cytoplasmic domain of Stx2
had little effect on surface TNF staining, whereas the Stx6 cytoplasmic domain significantly reduced surface TNF staining. aa, amino acids.
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Stx6 and Vti1b along with Stx7 were found to form a novel
Q-SNARE complex. A preliminary association of Stx7 with
Stx6 and Vti1b among several other SNARE coimmunoprecipi-
tating proteins in melanocytes has previously been noted (29).
Both Vti1b and Stx6 colocalize at the level of the Golgi, where
they are associated with the same Golgi-derived carriers as
those carrying the cargo TNF. The most direct role foreseen
for Vti1b/Stx6 is in the generation of TNF carriers at the
TGN; other possibilities include a role in regulating membrane
recycling back to the TGN for carrier formation. Future studies
will address these issues.
It is widely believed that trafficking proteins such as the
SNAREs perform basic housekeeping functions in the cell and
as such are constitutively expressed. Here we show that indi-
vidual SNARE proteins are regulated to perform specialized
functions in the cell. Macrophages are unique in their require-
ments for stimulus-coupled, temporal secretion of cytokines.
The changes in the trafficking machinery we see here now help
to explain how macrophages accommodate these requirements.
Increasing essential SNARE complexes facilitates vesicle fu-
sion required for the transport of cytokine from the Golgi to the
cell surface, a process that is critical to the immune response
but one with negative outcomes in inflammatory disease (1).
These findings now add a new facet to the emerging knowledge
that macrophages have uniquely adapted their trafficking
pathways to enable dynamic roles in the immune response.
Other recent and notable examples include the use of endoplas-
mic reticulum by the macrophage to supply additional mem-
brane to the plasma membrane for phagosome production and
to allow antigen cross-presentation to occur (30, 31). Our stud-
ies reveal an alternative mechanism that also provides addi-
tional membrane flow, in this case, in post-Golgi pathways to
enable macrophages to release cytokine.
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